Seven New Cannabinoids Discovered in High-Potency Cannabis

Scientists isolated seven previously unknown hydroxylated cannabinoids from high-potency cannabis, with one compound showing the highest CB1 receptor affinity and the most potent THC-like effects in mice.

Radwan, Mohamed M et al.·Journal of natural products·2015·Preliminary EvidenceObservational
RTHC-01046ObservationalPreliminary Evidence2015RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Researchers isolated and characterized seven new naturally occurring cannabinoids from high-potency Cannabis sativa, all of which were hydroxylated (oxygen-containing) variants of known cannabinoids.

When tested for binding to cannabinoid receptors, compound 3 (10-alpha-hydroxy-delta-8-THC) showed the highest affinity for CB1 receptors and produced the most potent cannabimimetic effects in mice (reduced movement, lowered body temperature, reduced pain sensitivity, and catalepsy). Compound 4 showed partial cannabimimetic actions, while compound 2 only produced reduced movement.

The discovery that high-potency cannabis contains novel psychoactive compounds beyond THC expands understanding of what users are actually consuming and what contributes to the effects of modern cannabis products.

Key Numbers

7 new cannabinoids isolated; 1 known compound (cannabiripsol) also studied; compound 3 had highest CB1 affinity and most potent behavioral effects; 10 compounds tested total

How They Did This

Natural products chemistry study isolating cannabinoids from high-potency Cannabis sativa using chromatography. Structures determined by NMR, GC-MS, and high-resolution mass spectrometry. Binding affinity measured at CB1 and CB2 receptors. Behavioral effects tested in mice using the tetrad assay.

Why This Research Matters

High-potency cannabis is not simply "more THC." This study revealed that it contains novel cannabinoids with their own receptor binding profiles and behavioral effects, complicating assumptions about what users are exposed to.

The Bigger Picture

Cannabis pharmacology is more complex than often assumed. The discovery of new psychoactive compounds in high-potency cannabis suggests that the health effects of modern cannabis products may be driven by more than just THC content.

What This Study Doesn't Tell Us

Structural characterization and receptor binding are preliminary steps. In vivo testing was limited to a standard mouse behavioral battery. The concentrations of these new compounds in typical cannabis products were not quantified. Only one cannabis variety was studied.

Questions This Raises

  • ?How much do these novel cannabinoids contribute to the effects of high-potency cannabis?
  • ?Are they present in significant amounts in consumer products?
  • ?Do they interact synergistically with THC?
  • ?Could they have therapeutic applications?

Trust & Context

Key Stat:
7 new cannabinoids discovered in high-potency cannabis
Evidence Grade:
Novel natural products chemistry with receptor binding and behavioral data. Important discovery, but clinical significance of these compounds is unknown.
Study Age:
Published in 2015. Cannabis chemistry research has continued to identify additional novel compounds.
Original Title:
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.
Published In:
Journal of natural products, 78(6), 1271-6 (2015)
Database ID:
RTHC-01046

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Are there cannabinoids besides THC and CBD?

Yes, many. This study alone identified seven previously unknown cannabinoids, bringing the total number of known cannabis compounds well beyond the commonly discussed THC and CBD. Over 100 cannabinoids have been identified in Cannabis sativa.

Does high-potency cannabis have different compounds than regular cannabis?

This study found novel hydroxylated cannabinoids specifically in high-potency cannabis. Whether these compounds are unique to high-potency varieties or simply present in detectable amounts only when overall cannabinoid production is high is an open question.

Read More on RethinkTHC

Cite This Study

RTHC-01046·https://rethinkthc.com/research/RTHC-01046

APA

Radwan, Mohamed M; ElSohly, Mahmoud A; El-Alfy, Abir T; Ahmed, Safwat A; Slade, Desmond; Husni, Afeef S; Manly, Susan P; Wilson, Lisa; Seale, Suzanne; Cutler, Stephen J; Ross, Samir A. (2015). Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.. Journal of natural products, 78(6), 1271-6. https://doi.org/10.1021/acs.jnatprod.5b00065

MLA

Radwan, Mohamed M, et al. "Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.." Journal of natural products, 2015. https://doi.org/10.1021/acs.jnatprod.5b00065

RethinkTHC

RethinkTHC Research Database. "Isolation and Pharmacological Evaluation of Minor Cannabinoi..." RTHC-01046. Retrieved from https://rethinkthc.com/research/radwan-2015-isolation-and-pharmacological-evaluation

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.